News Archive

Researchers have identified an enzyme that blocks chronic pain by robbing a major pain pathway of a key molecule.

Wednesday, April 13, 2011 - 12:12

Solving part of a medical mystery, researchers at the University of California, San Francisco (UCSF) have established a link between molecules found in an inflamed pancreas and the early formation of pancreatic cancer – a discovery that may help scientists identify new ways to detect, monitor and treat this deadly disease.

Tuesday, April 12, 2011 - 10:47

Researchers have identified a molecular mechanism that may explain why so many cancers spread to patients' bones -- they piggyback on signaling pathways that hematopoietic stem cells use to home to the bone marrow for self-renewal.



Tuesday, March 29, 2011 - 14:11

Researchers at Mount Sinai School of Medicine have discovered a way that mutations in a gene called LRRK2 may cause the most common inherited form of Parkinson's disease. The study, published online this month in the journal Public Library of Science, shows that upon specific modification called phosphorylation, LRRK2 protein binds to a family of proteins called 14-3-3, which has a regulatory function inside cells.

Friday, March 25, 2011 - 12:33

By sequencing the genome of a mouse with cancer, researchers at Washington University School of Medicine in St. Louis have uncovered mutations that also drive cancer in humans.

Thursday, March 24, 2011 - 13:42

A new study of prostate tumors has shown that a gene, FOXO3, suppresses activation of cells related to immunity and thus leads to a reduced immune response against a growing cancer. One of the main problems in treating cancer by vaccine or immunotherapy is that tumors often evade the body’s immune response — and one of their tricks is to create an environment where immunity is inhibited or suppressed.

Thursday, March 24, 2011 - 13:14

A combination approach for arresting and reversing amyloid plaque buildup in the brain has proven effective in studies of transgenic mice with this feature of Alzheimer's disease, said researchers from Baylor College of Medicine in a recent issue of The Journal of Neuroscience.

Thursday, March 24, 2011 - 11:29

Avian embryos could join the list of model organisms used to study a specific type of cell migration called epiboly.  The new study provides insights into the mechanisms of epiboly, a developmental process involving mass movement of cells as a sheet, which is linked with medical conditions that include wound healing and cancer.

Thursday, March 24, 2011 - 11:01

The latest clues suggesting potential new ways to treat melanoma come from an unlikely source: fish. Zebrafish don't get sunburns, but they can get skin cancer – at least those fish that have been engineered to model the often deadly human cancer.

Thursday, March 24, 2011 - 10:53

A unique antibody from a llama could prove to be a key weapon against C. difficile, a nasty infection that is a growing problem in many hospitals throughout North America.  Clostridium difficile is a common cause of infectious diarrhea in nursing homes and hospitals and usually occurs in patients who have been taking regular antibiotics for an infection.

Wednesday, March 23, 2011 - 12:17

A new NIH grant will allow biologist Robert Reenan the opportunity to study the genetics of epilepsy using an unusual method. His goal is to discover mutations that suppress seizures.

Tuesday, March 22, 2011 - 13:02

By mutating a single gene, researchers at MIT and Duke have produced mice with two of the most common traits of autism — compulsive, repetitive behavior and avoidance of social interaction. They further showed that this gene, which is also implicated in many cases of human autism, appears to produce autistic behavior by interfering with communication between brain cells.

Monday, March 21, 2011 - 12:59

A new way of delivering drugs to the brain has been developed by scientists at the University of Oxford.  They used the body's own transporters - exosomes - to deliver drugs in an experiment on mice.

Monday, March 21, 2011 - 12:44

It's been more than 20 years since scientists first discovered the gene that causes cystic fibrosis (CF), yet questions about how the mutated gene causes disease remain unanswered.  Using a newly created pig model that genetically replicates the most common form of cystic fibrosis, University of Iowa researchers have now shown that the CF protein is "misprocessed" in the pigs and does not end up in the correct cellular location.

Friday, March 18, 2011 - 09:30

A new protein engineered to inhibit molecules that cause inflammation not only reduces symptoms of rheumatoid arthritis in mice but also may have potential to reverse the disease's course. Researchers hope the findings will point toward a new therapy for this crippling and difficult-to-treat disease, which occurs when the immune system attacks the body's own joints.

Thursday, March 17, 2011 - 11:05

The small study in The Lancet Neurology used a virus to add genes to brain cells, which resulted in reduced symptoms for half of patients.

Thursday, March 17, 2011 - 09:55

Dana-Farber Cancer Institute scientists report that they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.

Wednesday, March 16, 2011 - 09:49

Scientists at Cambridge University believe the technique, which uses stem cells, could even cure blindness one day. They have already had success in rats and hope to start trials in humans within five years.

Tuesday, March 15, 2011 - 12:29

A new study suggests that combining two experimental anticancer peptide agents might simultaneously block formation of new tumor blood vessels while also inhibiting the growth of tumor cells.

Tuesday, March 15, 2011 - 11:47

In a research study appearing in the journal Cancer Cell on March 14, scientists from Cold Spring Harbor Laboratory (CSHL) and four other institutions have identified a strategy for targeted molecular therapy in liver cancer, which currently has limited treatment options and one of the worst one-year survival rates of any cancer type.

Tuesday, March 15, 2011 - 11:37